Growth Metrics

Resmed (RMD) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $28.5 million.

  • Resmed's Capital Expenditures rose 3824.36% to $28.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $122.9 million, marking a year-over-year increase of 4532.97%. This contributed to the annual value of $89.9 million for FY2025, which is 964.71% down from last year.
  • As of Q4 2025, Resmed's Capital Expenditures stood at $28.5 million, which was up 3824.36% from $43.0 million recorded in Q3 2025.
  • Over the past 5 years, Resmed's Capital Expenditures peaked at $48.4 million during Q1 2022, and registered a low of $17.8 million during Q3 2024.
  • Over the past 5 years, Resmed's median Capital Expenditures value was $28.2 million (recorded in 2021), while the average stood at $28.5 million.
  • Per our database at Business Quant, Resmed's Capital Expenditures tumbled by 4060.26% in 2024 and then soared by 14083.52% in 2025.
  • Over the past 5 years, Resmed's Capital Expenditures (Quarter) stood at $30.4 million in 2021, then dropped by 10.05% to $27.4 million in 2022, then dropped by 14.61% to $23.4 million in 2023, then decreased by 11.6% to $20.6 million in 2024, then surged by 38.24% to $28.5 million in 2025.
  • Its last three reported values are $28.5 million in Q4 2025, $43.0 million for Q3 2025, and $30.6 million during Q2 2025.